Quote | Ocuphire Pharma Inc Com (NASDAQ:OCUP)
Last: | $1.525 |
---|---|
Change Percent: | 1.27% |
Open: | $1.56 |
Close: | $1.525 |
High: | $1.58 |
Low: | $1.5 |
Volume: | 151,361 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Ocuphire Pharma Inc Com (NASDAQ:OCUP)
FARMINGTON HILLS, Mich., June 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today anno...
2024-05-10 08:05:37 ET More on Ocuphire Pharma Seeking Alpha’s Quant Rating on Ocuphire Pharma Historical earnings data for Ocuphire Pharma Financial information for Ocuphire Pharma Read the full article on Seeking Alpha For further details see...
Message Board Posts | Ocuphire Pharma Inc Com (NASDAQ:OCUP)
Subject | By | Source | When |
---|---|---|---|
skip | Dr_Vonschellan | investorshub | 11/29/2022 7:28:47 PM |
$OCUP CompanyOverview | conix | investorshub | 11/23/2022 4:10:05 PM |
If it wasn't for the election stuff, this | KOmani | investorshub | 11/08/2022 4:00:21 PM |
Analysts calling for 24-26$ target | PennyPusher786 | investorshub | 11/08/2022 3:19:40 PM |
This may just rise all day with that | PennyPusher786 | investorshub | 11/08/2022 3:03:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Ocuphire Pharma Inc Com Company Name:
OCUP Stock Symbol:
NASDAQ Market:
Ocuphire Pharma Inc Com Website:
FARMINGTON HILLS, Mich., June 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today anno...
FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial r...
FARMINGTON HILLS, Mich., May 06, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today announced that clinical data...